These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36217992)

  • 1. Early onset of azithromycin to prevent CLAD in lung transplantation: Promising results of a retrospective single centre experience.
    Cristeto Porras M; Mora Cuesta VM; Iturbe Fernández D; Tello Mena S; Alonso Lecue P; Sánchez Moreno L; Miñambres García E; Naranjo Gozalo S; Izquierdo Cuervo S; Cifrián Martínez JM
    Clin Transplant; 2023 Jan; 37(1):e14832. PubMed ID: 36217992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast in chronic lung allograft dysfunction after lung transplantation.
    Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
    J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival.
    Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K
    J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection.
    Combs MP; Luth JE; Falkowski NR; Wheeler DS; Walker NM; Erb-Downward JR; Wakeam E; Sjoding MW; Dunlap DG; Admon AJ; Dickson RP; Lama VN
    Am J Respir Crit Care Med; 2024 Jun; 209(11):1360-1375. PubMed ID: 38271553
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.
    Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM
    Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
    Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
    J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study.
    Testaert H; Bouet M; Valour F; Gigandon A; Lafon ME; Philit F; Sénéchal A; Casalegno JS; Blanchard E; Le Pavec J; Ader F
    Clin Microbiol Infect; 2021 Jun; 27(6):897-903. PubMed ID: 32827713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of statin treatment and exposure on the risk of chronic allograft dysfunction in Chinese lung transplant recipients.
    Zhang D; Wang X; Du W; Qin W; Chen W; Zuo X; Li P
    Pulm Pharmacol Ther; 2023 Oct; 82():102243. PubMed ID: 37454870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Lymphocytic Bronchitis Severity in the Era of Azithromycin Prophylaxis.
    Santos J; Hays SR; Golden JA; Calabrese DR; Kolaitis N; Kleinhenz ME; Shah R; Estrada AV; Leard LE; Kukreja J; Singer JP; Greenland JR
    Transplant Direct; 2023 Sep; 9(9):e1495. PubMed ID: 37575951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung volumes predict survival in patients with chronic lung allograft dysfunction.
    Kneidinger N; Milger K; Janitza S; Ceelen F; Leuschner G; Dinkel J; Königshoff M; Weig T; Schramm R; Winter H; Behr J; Neurohr C
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin and early allograft function after lung transplantation: A randomized, controlled trial.
    Van Herck A; Frick AE; Schaevers V; Vranckx A; Verbeken EK; Vanaudenaerde BM; Sacreas A; Heigl T; Neyrinck AP; Van Raemdonck D; Dupont LJ; Yserbyt J; Verleden SE; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Mar; 38(3):252-259. PubMed ID: 30686699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial.
    Ruttens D; Verleden SE; Vandermeulen E; Bellon H; Vanaudenaerde BM; Somers J; Schoonis A; Schaevers V; Van Raemdonck DE; Neyrinck A; Dupont LJ; Yserbyt J; Verleden GM; Vos R
    Am J Transplant; 2016 Jan; 16(1):254-61. PubMed ID: 26372728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection.
    Federica M; Nadia S; Monica M; Alessandro C; Tiberio O; Francesco B; Mario V; Maria FA
    Clin Transplant; 2011; 25(4):E381-9. PubMed ID: 21418327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung Density Analysis Using Quantitative Chest CT for Early Prediction of Chronic Lung Allograft Dysfunction.
    Horie M; Levy L; Houbois C; Salazar P; Saito T; Pakkal M; OʼBrien C; Sajja S; Brock K; Yasufuku K; Keshavjee S; Paul N; Martinu T
    Transplantation; 2019 Dec; 103(12):2645-2653. PubMed ID: 31343572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungal infection and colonization in lung transplant recipients with chronic lung allograft dysfunction.
    Pennington KM; Aversa M; Martinu T; Johnson B; Husain S
    Transpl Infect Dis; 2022 Dec; 24(6):e13986. PubMed ID: 36380578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithymocyte Globulin Treatment for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients: Experience From a National Reference Transplant Center.
    Margallo Iribarnegaray J; De Pablo Gafas A; Alonso Moralejo R; Quezada Loaiza CA; Revuelta Salgado F; Pina Maíquez I; Pérez González VL
    Transplant Proc; 2021 Nov; 53(9):2710-2717. PubMed ID: 34593251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The healthcare resource utilization and costs of chronic lung allograft dysfunction following lung transplantation in patients with commercial insurance in the United States.
    Sheshadri A; Sacks NC; Healey B; Cyr P; Boerner G; Huang HJ
    J Med Econ; 2022; 25(1):650-659. PubMed ID: 35502563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of methacholine challenge test with diagnosis of chronic lung allograft dysfunction in lung transplant patients.
    Siddiqui AS; Kumar G; Majumdar T; Graviss EA; Nguyen DT; Goodarzi A; Kaleekal T
    Clin Transplant; 2018 Oct; 32(10):e13397. PubMed ID: 30192029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector immune cells in chronic lung allograft dysfunction: A systematic review.
    Bos S; Filby AJ; Vos R; Fisher AJ
    Immunology; 2022 May; 166(1):17-37. PubMed ID: 35137398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.